Pathogens and Autoantigens

The entry "Pathogens and Autoantigens" refers collectively to: - **Pathogens**: these are foreign biological agents such as viruses, bacteria, fungi, and parasites that can trigger the immune system to mount protective responses, leading to infection-related immune reactions[7][8]. - **Autoantigens**: these are endogenous (self) molecules against which the immune system inappropriately mounts a response, resulting in autoimmune diseases such as systemic lupus erythematosus, rheumatoid arthritis, and multiple sclerosis[3][4][5][7]. Autoantigens are identified and targeted by the patient's own antibodies (autoantibodies) or T-cells, leading to tissue damage and disease[1][3][5][6]. In the context of *therapeutic targets*, both pathogens and autoantigens are vast, non-specific categories used in immunology and clinical medicine. Each consists of a large number of molecular structures (individual viral proteins, bacterial surface proteins, self-proteins, nucleic acid complexes, etc.) that may serve as individual drug or diagnostic targets[5][6]. However, the term as stated is too broad to map to a unique molecule, receptor, or protein. - *Pathogens* are addressed via antimicrobials, antivirals, vaccines, and immunotherapies, each targeting specific molecules on or produced by the pathogen. - *Autoantigens* are the basis for the development of autoantibody-based diagnostics and are sometimes direct targets for emerging therapeutics in autoimmunity, but each named autoimmune disease is associated with distinct autoantigens[4][5]. "Pathogens and Autoantigens" is not the canonical name nor abbreviation for an individual molecular therapeutic target[5][7]. It should not be used as such. Instead, specific molecules (e.g., insulin in type 1 diabetes, citrullinated peptides in rheumatoid arthritis, viral envelope proteins) must be identified for structured therapeutic or diagnostic purposes.